PUBLICATIONS
2024
Kim SS, Cheong JY. The Urgent Need for Multidisciplinary Approaches in Managing Alcohol-Associated Liver Disease. Clinical and molecular hepatology. 2024 Oct 7. (Editorial)
IF : 14.0
Ahn HR*, Kim SJ*, Baek GO, Yoon MG, Kang M, Ng JT, Go Y, Lim SB, Yoon JH, Jeong JY, Han JE, Kim SS, Cheong JY, Eun JW, Cho HJ. Effect of Sortilin1 on promoting angiogenesis and systemic metastasis in hepatocellular carcinoma via the Notch signaling pathway and CD133. Cell Death and Disease. 2024 Aug 29.
IF : 8.1
Hong J*, Eun JW*, Baek GO, Cheong JY, Park S, Kim SS, Cho HJ, Lim SB. Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma. Clinical and Molecular Hepatology. 2024 Mar 15. 한빛사논문
IF : 14.0
Han JE*, Kim J*, Cheong JY, Kim SS, Lim SG, Yang MJ, Noh CK, Lee GH, Eun JW, Park B, Cho HJ. The Impact of Statins on the Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib or Lenvatinib. Cancers (Basel). 2024 Jan 5;16(2):249.
IF : 4.5
2023
Son JA*, Weon JH*, Baek GO, Ahn HR, Choi JY, Yoon MG, Cho HJ, Cheong JY, Eun JW, Kim SS. Circulating small extracellular vesicle-derived splicing factor 3b subunit 4 as a non-invasive diagnostic biomarker of early hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 2023; 42: 288. 한빛사논문
IF : 11.4
Eun JW*, Cheong JY, Jeong JY, Kim HS. A New Understanding of Long Non-Coding RNA in Hepatocellular Carcinoma-From m(6)A Modification to Blood Biomarkers. Cells. 2023 Sep 14;12(18):2272
IF : 5.1
Kim HS*, Yoon JH*, Baek GO, Yoon MG, Han JE, Cho HJ, Kim SS, Jeong JY, Cheong JY, Eun JW. Tumor Endothelial Cells-Associated Integrin Alpha-6 as a Promising Biomarker for Early Detection and Prognosis of Hepatocellular Carcinoma. Cancers (Basel). 2023 Aug 17;15(16):4156.
IF : 4.5
Eun JW*, Yoon JH*, Ahn HR*, Kim S, Kim YB, Lim SB, Park W, Kang TW, Baek GO, Yoon MG, Son JA, Weon JH, Kim SS, Cho HJ, Cheong JY. Cancer-associated fibroblast-derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib. Cancer Communications. 2023 Apr;43(4):455-479. 한빛사논문
IF : 20.1
Eun JW*, Ahn HR*, Baek GO, Yoon MG, Son JA, Weon JH, Yoon JH, Kim HS, Han JE, Kim SS, Cheong JY, Kim BW, Cho HJ. Aberrantly Expressed MicroRNAs in Cancer-Associated Fibroblasts and Their Target Oncogenic Signatures in Hepatocellular Carcinoma. International Journal of Molecular Sciences. 2023 Feb 21;24(5):4272.
IF : 4.9
2022
Ahn HR*, Baek GO*, Yoon MG, Son JA, Yoon JH, Cheong JY, Cho HJ, Kang HC, Eun JW, Kim SS. Hypomethylation-mediated upregulation of the WASF2 promoter region correlates with poor clinical outcomes in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 2022 Apr 28;41(1):158. 한빛사논문
IF : 11.4
Son JA*, Ahn HR*, You D, Baek GO, Yoon MG, Yoon JH, Cho HJ, Kim SS, Nam SW, Eun JW, Cheong JY. Novel Gene Signatures as Prognostic Biomarkers for Predicting the Recurrence of Hepatocellular Carcinoma. Cancers (Basel). 2022 Feb 9;14(4):865.
IF : 4.5
Kim SS, Cheong JY. Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations. Clinical and Molecular Hepatology. 2022 Oct;28(4):802-805. (Editorial)
IF : 14.0
2021
Ahn HR*, Baek GO, Yoon MG, Son JA, You D, Yoon JH, Cho HJ, Kim SS, Cheong JY, Eun JW. HMBS is the most suitable reference gene for RT-qPCR in human HCC tissues and blood samples. Oncology Letters. 2021 Nov;22(5):79
IF : 2.5
Cho HJ*, Baek GO, Yoon MG, Ahn HR, Son JA, Kim SS, Cheong JY, Eun JW. Overexpressed Proteins in HCC Cell-Derived Exosomes, CCT8, and Cofilin-1 Are Potential Biomarkers for Patients with HCC. Diagnostics (Basel). 2021 Jul 6;11(7):1221.
IF : 3.0
Kim SS*, Baek GO, Son JA, Ahn HR, Yoon MK, Cho HJ, Yoon JH, Nam SW, Cheong JY, Eun JW. Early detection of hepatocellular carcinoma via liquid biopsy: panel of small extracellular vesicle-derived long noncoding RNAs identified as markers. Molecular Oncology. 2021 Oct;15(10):2715-2731
IF : 5.0
Lee GH*, Cho HJ, Lee G, Kim HG, Wang HJ, Kim BW, Lee MY, Yoon SY, Noh CK, Seo CW, Eun JW, Cheong JY, Cho SW, Kim SS. Bioelectrical impedance analysis for predicting postoperative complications and survival after liver resection for hepatocellular carcinoma. Annals of Translational Medicine. 2021 Feb;9(3):190.
IF : 3.9
Han JE*, Cho HJ, Kim SS, Cheong JY. Infiltrative hepatocellular carcinoma with multiple lung metastasis completely cured using nivolumab: a case report. Journal of Liver Cancer. 2021 Sep;21(2):169-176
Cho HJ*, Cheong JY. Role of Immune Cells in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma. International Journal of Molecular Sciences. 2021 Jul 27;22(15):8011
IF : 4.9
2020
Eun JW*, Seo CW, Baek GO, Yoon MG, Ahn HR, Son JA, Sung S, Kim DW, Kim SS, Cho HJ, Cheong JY. Circulating Exosomal MicroRNA-1307-5p as a Predictor for Metastasis in Patients with Hepatocellular Carcinoma. Cancers (Basel). 2020 Dec 18;12(12):3819.
IF : 4.5
Kim SS*, Eun JW*, Choi JH, Woo HG, Cho HJ, Ahn HR, Suh CW, Baek GO, Cho SW, Cheong JY. MLH1 single-nucleotide variant in circulating tumor DNA predicts overall survival of patients with hepatocellular carcinoma. Scientific Reports. 2020 Oct 20;10(1):17862.
IF : 3.8
Cho HJ*, Baek GO, Seo CW, Ahn HR, Sung S, Son JA, Kim SS, Cho SW, Jang JW, Nam SW, Cheong JY, Eun JW. Exosomal microRNA-4661-5p-based serum panel as a potential diagnostic biomarker for early-stage hepatocellular carcinoma. Cancer Medicine. 2020 Aug;9(15):5459-5472.
IF : 2.9
Kim SS*, Baek GO, Ahn HR, Sung S, Seo CW, Cho HJ, Nam SW, Cheong JY, Eun JW. Serum small extracellular vesicle-derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma. Molecular Oncology. 2020 Oct;14(10):2646-2659.
IF : 5.0
Cho HJ*, Eun JW*, Baek GO, Seo CW, Ahn HR, Kim SS, Cho SW, Cheong JY. Serum Exosomal MicroRNA, miR-10b-5p, as a Potential Diagnostic Biomarker for Early-Stage Hepatocellular Carcinoma. Journal of Clinical Medicine. 2020 Jan 20;9(1):281
IF : 3.0
2019
Kim SS*, Eun JW, Cho HJ, Lee HY, Seo CW, Noh CK, Shin SJ, Lee KM, Cho SW, Cheong JY. Effect of Fibroblast Growth Factor-2 and its Receptor Gene Polymorphisms on the Survival of Patients With Hepatitis B Virus-associated Hepatocellular Carcinoma. Anticancer Research. 2019 Apr;39(4):2217-2226.
IF : 2.0